Careaga-Reyna G, Zetina-Tun H, Villaseñor-Colín C, Alvarez-Sánchez LM, Urías-Báez R, Cerda-Belmont GA

Language: Spanish
References: 22
Page: 424-428
PDF size: 110.75 Kb.

ABSTRACT

Background: the low availability of organ donors is a serious hindrance to heart transplantation. Long-distance organ procurement has been accepted as an option despite longer ischemic time for the heart.
Methods: long-distance procurement from outside Mexico City in adult patients with terminal heart failure submitted to orthotopic heart transplantation between February 1st 2011, and January 31st 2012, was assessed. Ischemic time, distance from Mexico City, and perioperative and short-time mortality were determined.
Results: there were 14 orthotopic heart transplants during the analyzed period. In 12 cases long-distance heart procurement was required. Mean age of recipients was 42.7 years (range between 17 and 61 years). Seven patients were male and five female. Mean ischemic time was 228.58 minutes. The longest distance of procurement for land and air travel was 2,319 km; and the lowest, 22.5 km. Perioperative mortality was 8.33% (one patient), and there were 2 short-term deaths due to non-cardiac complications. In this series we included a case of heart-kidney transplantation from same donor.
Conclusion: at our hospital, long-distance procurement for heart transplantation is a useful procedure with good results.

REFERENCES

1. Tjang Y, van der Heijden G, Tenderich G, Grobbee D, Körfer R. Survival analysis in heart transplantation: results from an analysis of 1290 cases in a single center. Eur J Cardiothorac Surg 2008;33(5):856-861.

2. O’Connell J, Bourge RC, Costanzo-Nordin MR, Driscoll DJ, Morgan JP, Rose EA, et al. Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992;86(3);1062-1079.

3. Stehlik J, Edwards L, Kucheryavaya A, Benden C, Christie J, Dobbels F, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-eight adult heart transplant report- 2011. J Heart Lung Transplant 2011;30(10):1078-1094.

4. Costanzo RM, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29(8):914-956.

5. Mitropoulos FA, Odim J, Marelli D, Karandikar K, Gjertson D, Ardehali A, et al. Outcome of hearts with cold ischemic time greater than 300 minutes: a case-matched study. Eur J Cardiothotacic Surg 2005;28(1):143-148.

6. Morgan J, John R, Weinberg AD, Kherani AR, Coletti NJ, Vigilance DW, et al. Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg 2003;126(5):1624-1633.

7. Briganti EM, Bergin PJ, Rosenfeldt FL, Esmore DS, Rabinov M. Successful long-term outcome with prolonged ischemic time cardiac allografts. J Heart Lung Transplant 1995:14(5):840-845.

8. Thomas F, Szentpetery S, Mammana E, Wolfang T, Lower R. Longdistance transportation of human hearts for transplantation. Ann Thorac Surg 1978;26(4):344-350.

9. Russo M, Chen J, Sorabella R, Martens T, Garrido M, Davies RR, et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the united network for organ sharing database. J Thorac Cardiovasc Surg 2007;133(2):554-559.

10. Scheule A, Zimmerman G, Johnston J, Razzouk A, Gundry S, Bailey L, et al. Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients. Circulation 2002;106 (suppl I):I163-I167.

11. Careaga-Reyna G, Zetina-Tun H, Lezama-Urtecho CA. Programa de trasplante cardiaco de la Unidad Médica de Alta Especialidad, Hospital General Dr. Gaudencio González Garza, del Centro Médico Nacional “La Raza”. Rev Invest Clin 2011;63(supl 1):85-90.

12. Zaroff J, Rosengard R, Armstron W, Babcoc W, Alesandro A, Dec W. Maximizing use of organs recovered from the cadaver donor: cardiac recommendations. Circulation 2002;106(7):836-841.

13. Omoto T, Minami K, Böthig D, Schütt U, Tenderich G, Wlost S, et al. Risk factor analysis of orthotopic heart transplantation. Asian Cardiovasc Thorac Ann 2003;11(1):33-36.

14. Blanche C, Kamlot A, Blanche D, Kearney B, Wong A, Czer L, et al. Combined heart-kidney transplantation with single-donor allografts. J Thorac Cardiovasc Surg 2001;122(3):495-500.

15. Bruschi G, Busnach G, Colombo T, Radaelli L, Pedrazzini G, Garatti A, et al. Long- term follow-up of simultaneous heart and kidney transplantation with single donor allografts: Report of nine cases. Ann Thorac Surg 2007;84(2):522-527.

16. McKay GS, Haydock DA, Bourchier R, Ruygrok PN, Agnew TM, Coverdale HA, et al. Cardiac and delayed renal transplantation with same-donor allografts. Asian Cardiovasc Thorac Ann 2000;8(2):164- 166.

17. Reichenspurner H, Russ C, Überfuhr P, Nollert G, Schlüter A, Reichart B, et al. Myocardial preservation using HTK solution for heart transplantation. Eur J Cardiothorac Surg 1993;7(8):414-419.

18. Lower R, Shumway N. Studies on orthotopic homotransplantation of the canine heart. Surg Forum 1960;11:18-19.

19. Shumway NE, Lower RR, Stofer RC. Transplantation of the heart. Adv Surg 1966;2:265-284.

20. Argüero R, Castaño R, Portilla E, Sánchez O, Molinar F. Primer caso de trasplante de corazón en México. Rev Med IMSS 1989;27:107- 109.

21. Argüero R, Castaño R, Careaga G. Trasplante de corazón, pulmón y corazón pulmón. Capítulo 6. Donadores. Ed. Salvat. México, 1995. p. 32-42.

22. Careaga-Reyna G, Ramírez-Castañeda S, Ramírez-Castañeda A Importancia de la evaluación terciaria del potencial donador en trasplante de corazón. Rev Mex Cardiol 2008;19(3):149-151.